PROCESSING OF HCG IN NORMAL AND ABNORMAL PREGNANCIES
Project Number1R21HD035654-01A1
Former Number1R01HD035654-01A1
Contact PI/Project LeaderCOLE, LAURENCE ANTHONY
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
Preliminary studies in our laboratory are consistent with a relationship
between hyperglycosylation (additional antennae and fucose residues on
N-linked oligosaccharides) and nicking or cleavage of hCG. Other
preliminary studies indicate the structural instability and diminished
biological activity of hyperglycosylated and of nicked hCG molecules,
and how they may be the source of free Beta-subunit in the circulation
and Beta-core fragment in urine samples. A large number of papers have
been published showing raised hCG levels, and raised proportions of free
Beta-subunit and Beta-core fragment levels in serum or urine samples
from patients with Down syndrome pregnancies, preeclampsia, trophoblast
disease, or hyperemesisgravidarum. It is our hypothesis, that all of
these raised levels arise from the hyperglycosylation of hCG, through
a pathway involving nicking of hyperglycosylated hCG, ineffective
autocrine control of hCG production, and rapid dissociation to generate
nicked free Beta-subunit, and degradation to Beta-core fragment. Five
sets of experiments are proposed to test this hypothesis and investigate
the clinical ramification of the observations in normal and abnormal
pregnancies. Studies are proposed to confirm and compare the levels of
hCG, free Beta-subunit and Beta-core fragment in 720 sets of parallel
serum and urine samples from normal and abnormal pregnancies (Aim 1A);
to purify hCG from normal first, second, and third trimester pregnancy
urine samples and trophoblast disease, preeclampsia, hyperemesisgravidarum and Down syndrome pregnancy urine samples (3 each) and
compare the extents and sites of nicking, and the type, amounts and
locations of hyperglycosylated N-linked oligosaccharides (Aim 2); to
investigate the hyperglycosylation-nicking relationship by comparing
normal and hyperglycosylated hCG as substrates for nicking enzymes (Aim
3); to examine the biological activities of normal and abnormal
pregnancy hCG and abilities to feedback through to the placenta and
control hCG synthesis (Aim 4); to investigate the and compare the
stabilities of hCG from normal and abnormal pregnancy, and determine
whether dissociation could explain the raised proportion of free Beta-
subunit (Aim 5); and to use the parallel serum and urine samples to
investigate the clinical utility of new immunoassays specifically
measuring nicked or hyperglycosylated hCG molecules (Aim 1B).
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Downs syndrome biomarker blood chemistry carbohydrate structure choriocarcinoma chorionic gonadotropin clinical research gel filtration chromatography gestational age glycoprotein structure glycosylation human pregnant subject ion exchange chromatography oligosaccharides preeclampsia pregnancy disorder prenatal diagnosis protein purification protein sequence tissue /cell culture urinalysis
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-September-1998
Project End Date
31-December-1998
Budget Start Date
01-September-1998
Budget End Date
31-December-1998
Project Funding Information for 1998
Total Funding
$49,361
Direct Costs
$39,489
Indirect Costs
$9,872
Year
Funding IC
FY Total Cost by IC
1998
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$49,361
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R21HD035654-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21HD035654-01A1
Patents
No Patents information available for 1R21HD035654-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21HD035654-01A1
Clinical Studies
No Clinical Studies information available for 1R21HD035654-01A1
News and More
Related News Releases
No news release information available for 1R21HD035654-01A1
History
No Historical information available for 1R21HD035654-01A1
Similar Projects
No Similar Projects information available for 1R21HD035654-01A1